TSX:IGX (IntelGenx Technologies)

About IGX

IntelGenx Technologies Corp. is a drug delivery company, which focuses on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilm technology platform. Its products include rizaport, tadalafil, loxapine, and montelukast. The was founded on July 27, 1999 and is headquartered in Ville Saint-Laurent, Canada.
  • Should you invest $1,000 in Intelgenx Technologies right now?

    Before you buy stock in Intelgenx Technologies, consider this:

    The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Intelgenx Technologies wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

    Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,058.57!*

    Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 38 percentage points since 2013*.

    See the Top Stocks * Returns as of 2/20/25

  • IntelGenx Technologies (TSX: IGX) Latest News

    No posts found.